…mination This study and its protocols have been approved by the University of California, San Francisco (UCSF) Institutional Review Board and the scientific staff of H…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 115 of 2459…pigmentosa, 25.3/100 000; X-linked retinoschisis, 10.7/100 000; Usher syndrome, 8.9/100 000; choroideremia, 7/100 000 and cone or cone-rod dys…
…nd Flow diversion has emerged as a major treatment modality for intracranial aneurysms, but its adoption trajectory may differ fundamentally between r…
…(MMA) embolization is increasingly utilized in the treatment of chronic subdural hematomas (cSDH), most commonly as an adjunct to surgical evacuation. Prior stud…
…OR ‘meningeal artery’) AND (Avastin OR Bevacizumab OR ‘TXA’ OR ‘Tranexamic Acid’ OR ‘medication adjunct’) AND (embolization). These criteria we…
…n two items) and end effects suggested interpretability issues. Cognitive impairment severity neither correlated with completion time (Spearman’s, p…
…Background Despite the impact of depression in multiple sclerosis (MS), the neurobiological mechanisms underlying its pathogenesi…
…Background Diabetes is a major global public health challenge, with rapidly rising …
…cell lymphoma-2 (BCL-2)/BCL-extra-large (BCL-xL) inhibitor, and osimertinib in patients with EGFR-mutated advanced NSCLC.Methods Enrolled p…
…Background Multiple sclerosis (MS) is an autoimmune disease with complex aetiology involving …
…um (syphilis), Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis, remain a major global health concern; yet their epidemiology a…
… to examine the therapeutic and cost-effectiveness of combining MDMA with evidence-based integrated care for comorbid PTSD+AUD. Spec…